Table of Contents

Biopharmas are faced with many questions at launch that data helps answer. But even with the volume of data available today, about 34% of new product launches in the U.S. do not meet forecasts. Where are the gaps? A ³Ô¹Ï±¬ÁÏ survey of 125 commercial and data leaders reveals challenges like speed to insight for the field and data integration are top of mind.

Q

Why do over 33% of new product launches in the U.S. fail to meet forecasts?

A

The top challenge:
delivering insights to field teams quickly.

61%

of leaders say translating analytics into rapid field action is a top launch challenge

94%

of field teams don't receive daily alerts

What launch data challenges did you experience during your most recent launch?

Translating analytics into field action quickly
61%
Integrating disparate data sources and software
49%
Data latency/lack of real-time visibility
43%
Misalignment on KPIs/definition of success
43%
Lack of resources (forced to make tradeoffs)
37%
Skills gaps around generating insights from data
34%
Struggled to identify the right data sources
30%
No significant challenges
2%
Rapid field alert Rapid
field alert
Slow, traditional alerts mean field teams can miss critical opportunities to influence care.
Traditional field alert Traditional
field alert
within 24 hours
1¨C3 weeks

Daily insights for the field:

Improve HCP outreach
Optimize how field reps spend their time
Help more patients start on therapies faster
Read the full report: Fragmented Data Is Holding Back Biopharma Launches.